- Home
- AREC vs SNTI Comparison
AREC vs SNTI Comparison
Compare AREC & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AREC
- SNTI
- Stock Information
- Founded
- AREC 2013
- SNTI 2016
- Country
- AREC United States
- SNTI United States
- Employees
- AREC N/A
- SNTI N/A
- Industry
- AREC Coal Mining
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- AREC Energy
- SNTI Health Care
- Exchange
- AREC Nasdaq
- SNTI Nasdaq
- Market Cap
- AREC 71.7M
- SNTI 85.3M
- IPO Year
- AREC 2019
- SNTI N/A
- Fundamental
- Price
- AREC $0.92
- SNTI $2.17
- Analyst Decision
- AREC Strong Buy
- SNTI Strong Buy
- Analyst Count
- AREC 2
- SNTI 2
- Target Price
- AREC $4.00
- SNTI $8.50
- AVG Volume (30 Days)
- AREC 2.4M
- SNTI 342.2K
- Earning Date
- AREC 08-18-2025
- SNTI 08-12-2025
- Dividend Yield
- AREC N/A
- SNTI N/A
- EPS Growth
- AREC N/A
- SNTI N/A
- EPS
- AREC N/A
- SNTI N/A
- Revenue
- AREC $321,142.00
- SNTI N/A
- Revenue This Year
- AREC $25,437.66
- SNTI N/A
- Revenue Next Year
- AREC $156.28
- SNTI $150.00
- P/E Ratio
- AREC N/A
- SNTI N/A
- Revenue Growth
- AREC N/A
- SNTI N/A
- 52 Week Low
- AREC $0.38
- SNTI $1.52
- 52 Week High
- AREC $1.68
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- AREC 57.10
- SNTI 33.12
- Support Level
- AREC $0.63
- SNTI $2.56
- Resistance Level
- AREC $1.08
- SNTI $3.40
- Average True Range (ATR)
- AREC 0.13
- SNTI 0.43
- MACD
- AREC 0.03
- SNTI -0.09
- Stochastic Oscillator
- AREC 64.47
- SNTI 2.33
About AREC American Resources Corporation
American Resources Corp constructs and/or purchases and manages a chain of combined gasoline, diesel and natural gas (NG) fueling and service stations; construct conversion factories to convert NG to liquefied natural gas (LNG) and compressed natural gas (CNG); and construct conversion factories to retrofit vehicles currently using gasoline or diesel fuel to also run on NG in the United States and also to build a convenience store to serve its customers in each of its locations. Its segments are AIC focused on the extraction, processing, transportation, and distribution of coal for a variety of industries, with a focus on metallurgical quality coal to the steel industry; RLMT; and EMC.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.